HYPR
NASDAQ
US
Hyperfine, Inc. - Class A Common Stock
$1,13
▲ +$0,04
(+3,67%)
Vol. 221K
4
Punteggio di Qualità
fail
Ricavi ✗
Utile netto ✗
>IPO ✗
Cap. mercato
$95.2M
ROE
-103,9%
Margine
-378,2%
D/E
0,00
Beta
1,10
52W
$1–$2
Consenso Wall Street
8 analisti · Apr 20262
Acquisto forte
5
Compra
1
Mantieni
0
Vendi
0
Vendita forte
87,5%
Rating Compra
Grafico dei Prezzi
Titoli simili
Utili
Tasso di battuta: 40,0%
Prossimo report
Mag 11, 2026
Stima EPS: $-0,09
| Trimestre | EPS Stimato | EPS Effettivo | Sorpresa |
|---|---|---|---|
| Mar 2026 | $-0,09 | — | — |
| Dic 2025 | $-0,08 | $-0,05 | +$0,03 |
| Set 2025 | $-0,11 | $-0,11 | $0,00 |
| Giu 2025 | $-0,12 | $-0,12 | +$0,00 |
Ricavi e utili trimestrali
| Trimestre | 2024-0… | 2024-1… | 2025-0… | 2025-0… | 2025-0… |
|---|---|---|---|---|---|
| Ricavi | $3.6M | $2.3M | $2.1M | $2.7M | $3.4M |
| Utile netto | -$10.3M | -$10.4M | -$9.4M | -$9.2M | -$11.0M |
Trend fondamentali
| Metrica | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | -84.8% | -74.2% | -84.8% | -84.8% | -84.8% | -103.9% |
| P/E (TTM) | — | — | — | — | — | — |
| Net Margin | -342.2% | -343.4% | -364.5% | -364.5% | -364.5% | -378.2% |
| Gross Margin | 49.3% | 46.2% | 45.8% | 45.8% | 45.8% | 46.1% |
| D/E Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Current Ratio | 5.02 | 6.07 | 5.02 | 5.02 | 5.02 | 3.63 |
Rapporti chiave
ROA (TTM)
-80,5%
P/S (TTM)
8,98
P/B
1,3
EPS (TTM)
$-0,52
Crescita ricavi 3A
+105,0%
52W High
$2,22
52W Low
$0,53
$0,53
Intervallo 52 settimane
$2,22
Salute finanziaria
Flusso di cassa libero
-$5.7M
Debito netto
-$21.4M
Liquidità
$21.6M
Debito totale
$182K
Aggiornato al Set 30, 2025
Як HYPR виглядає на тлі конкурентів у Health Care?
Група порівняння: Micro-cap Health Care (All) · 241 компаній
Оцінка HYPR vs аналоги Health Care
P/E
—
▼
0%
sotto
peer
(30,7)
vs Peer
vs Settore
Sottovalutato
P/S
9,0
▲
248%
sopra
peer
(2,6)
vs Peer
vs Settore
Sopravvalutato
P/B
1,3
▼
53%
sotto
peer
(2,8)
vs Peer
vs Settore
Sottovalutato
Дивідендна дохідність
—
▼
0%
sotto
peer
(0,7%)
vs Peer
vs Settore
Rendimento basso
Прибутковість HYPR vs аналоги Health Care
ROE
-103,9%
▼
170%
sotto
peer
(-38,5%)
vs Peer
vs Settore
Debole
Net margin
-378,2%
▼
1432%
sotto
peer
(-24,7%)
vs Peer
vs Settore
Debole
Валова маржа
46,1%
▼
13%
sotto
peer
(52,9%)
vs Peer
vs Settore
Debole
ROA
-80,5%
▼
279%
sotto
peer
(-21,2%)
vs Peer
vs Settore
Debole
Фінансове здоровʼя HYPR vs аналоги Health Care
D/E ratio
0,0
▼
100%
sotto
peer
(19,3)
vs Peer
vs Settore
Debito basso
Поточна ліквідність
3,6
▲
68%
sopra
peer
(2,2)
vs Peer
vs Settore
Sotto media
Beta
1,1
▲
5%
sopra
peer
(1,1)
vs Peer
vs Settore
Meno volatile
Радар фундаменталів HYPR
HYPR
Mediana peer
Industria
HYPR прибутковість vs борг
Розмір бульбашки = капіталізація · X = чиста маржа · Y = D/E ratio
HYPR vs аналоги: ключові метрики
Attività insider
NeutralAcquisti
0
Vendite
0
HALE BRETT
Chief Financial Officer · Mar 23
24188 shs
TEISSEYRE THOMAS
Chief Operating Officer · Mar 23
24188 shs
TEISSEYRE THOMAS
Chief Operating Officer · Feb 13
821 shs
Ultimo 90 giorni
Principali azionisti
Top 5: 12,16%Vanguard Group Inc
4,35%
$4.0M
Sio Capital Management, LLC
2,44%
$2.2M
Fosun International Ltd
2,12%
$1.9M
Northern Trust Corporation
1,64%
$1.5M
Catalio Capital Management,…
1,61%
$1.5M
Aggiornato al Dic 31, 2025
Ultime notizie
Nessuna notizia correlata ancora